Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-28T15:53:16.160Z Has data issue: false hasContentIssue false
  • English
  • Français

Surgical Site Infections Following Birmingham Hip Resurfacing

Published online by Cambridge University Press:  09 August 2016

Ashish Bhargava ,
Madiha Salim ,
Harsha V. Banavasi ,
Vijay Neelam ,
Richmund Wenzel ,
Kristin L. Sims ,
Sorabh Dhar  and
Keith S. Kaye
Ashish Bhargava*
Affiliation:
Division of Infectious Diseases, St John Hospital and Medical Center, Grosse Pointe Woods, Michigan
Madiha Salim
Affiliation:
Division of Infectious Diseases, Wayne State University/ Detroit Medical Center, Detroit, Michigan
Harsha V. Banavasi
Affiliation:
Division of Infectious Diseases, Wayne State University/ Detroit Medical Center, Detroit, Michigan
Vijay Neelam
Affiliation:
Division of Infectious Diseases, Wayne State University/ Detroit Medical Center, Detroit, Michigan
Richmund Wenzel
Affiliation:
Division of Infectious Diseases, Wayne State University/ Detroit Medical Center, Detroit, Michigan
Kristin L. Sims
Affiliation:
Infection Control, Detroit Medical Center, Detroit, Michigan.
Sorabh Dhar
Affiliation:
Division of Infectious Diseases, Wayne State University/ Detroit Medical Center, Detroit, Michigan
Keith S. Kaye
Affiliation:
Division of Infectious Diseases, Wayne State University/ Detroit Medical Center, Detroit, Michigan
*
Address correspondence to Dr Ashish Bhargava, MD, FACP, 19251 Mack Avenue, Suite 340, Grosse Pointe Woods, MI 48236 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

The Birmingham Hip Resurfacing procedure (BHR) is metal-on-metal resurfacing procedure for hip arthritis. BHR was associated with low risk of surgical site infection (SSI; 0.6%). In addition to antimicrobials, superficial SSIs were treated with incision and drainage, whereas deep incisional or organ-space SSIs required removal of prosthesis.

Infect Control Hosp Epidemiol 2016;1–4

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 37 , Issue 11 , November 2016 , pp. 1383 - 1386
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION. Preliminary data of this study were presented at IDSA2013, San Francisco, California, October 2013.

References

REFERENCES

1. Makela, KT, Eskelinen, A, Pulkkinen, P, Paavolainen, , Remes, V. Results of 3,668 primary total hip replacements for primary osteoarthritis in patients under the age of 55 years. Acta Orthopaedica 2011;82:521–529.Google Scholar
2. Treacy, RB, McBrydee, CW, Shears, E, Pynsent, PB. Birmingham hip resurfacing: a minimum follow-up of ten years. J Bone Joint Surg Br 2011;93:27–33.Google Scholar
3. Azam, MQ, McMahon, S, Hawdon, G, Sankineani, SR. Survivorship and clinical outcome of Birmingham hip resurfacing: a minimum ten years’ follow-up. Int Orthop 2016;40:1–7.Google Scholar
4. Surgical site infection (SSI) event. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf. Published 2015. Accessed July 5, 2016.Google Scholar
5. Culver, DH, Horan, TC, Gaynes, RP, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 1991;91:S152–S157.Google Scholar
6. Lindeque, B, Hartman, Z, Noshchenko, A, Cruse, M. Infection after primary total hip arthroplasty. Orthopedics 2014 Apr;37:257–265.Google Scholar
7. Sewick, A, Makani, A, Wu, C, O’Donnell, J, Baldwin, KD, Lee, GC. Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty? Clin Orthop Relat Res 2012, Epub. DOI 10.1007/s11999-012-2255-1.Google Scholar
8. Finkelstein, R, Rabino, G, Mashiah, T, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg 2002;123:326–332.Google Scholar
9. Deverick, J. Anderson, Kelly, Podgorny, Sandra, I, Berríos-Torres, , et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemiol 2014;35:605–627.Google Scholar
10. Zimmerli, W, Trampuz, A, Ochsner, PE. Prosthetic-joint infections. N Engl J Med 2004;351:1645–1654.Google Scholar